Figure 3From: Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cellsEffect of alemtuzumab on megakaryocytes. Cells were cultured in the same condition as described in Fig 2 and harvested at Day 7 and Day 14 for analysis. A: Absolute CD41+ cell numbers. B: Relative CD41+ cell expansion with Alemtuzumab versus control. (N = 6, p < 0.05).Back to article page